Status:
RECRUITING
Evaluation of the Stability of Sulfur Volatile Compounds From Exhaled Air for Halitosis Diagnosis
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Halitosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Halitosis or bad breath is a problem affecting 30% of the world's population. There are many causes, and oral pathologies, including periodontitis, are the main etiology. In order to make a diagnosis,...
Eligibility Criteria
Inclusion
- Adult, male or female
- Subject affiliated with a social health insurance plan
- Able to understand the objectives and risks of the research and to give dated and signed informed consent
- Subject presenting for consultation for diagnosis and treatment of periodontal pathology
Exclusion
- Subject under safeguard of justice
- Subject under guardianship or curatorship
- Pregnancy or breast-feeding
- Impossibility of giving the subject informed information (subject in emergency situation, difficulties in understanding the subject, etc.)
- Subject currently included in another clinical research protocol or in an exclusion period
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06483646
Start Date
October 1 2024
End Date
September 1 2025
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique dentaire
Strasbourg, France, 67000